Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bluejay Diagnostics, Inc.

NASDAQ: BJDX · Industrial Applications and Services · 5 alerts · CIK 1704287

Share price
$2.29Close, Nov 16
Market cap
$2.56M
Shares outstanding
1.12MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bluejay Diagnostics, Inc. filings on SEC EDGAR ↗

4:07 PM ET 8-K
Business Update

Bluejay Diagnostics Business Update

Bluejay Diagnostics provided a corporate update for Q3 2026, highlighting the completion of enrollment for its SYMON-II clinical study and the establishment of an alternative manufacturing site ahead of schedule. The company reported a cash balance of $7.38 million and targets an FDA 510(k) submission for its Symphony IL-6 platform in the first half of 2027.

5:01 PM ET 10-Q
Financial Results

Bluejay Diagnostics Q3 2026 Results: Net Loss of $2.01M, Loss Widens

Bluejay Diagnostics reported a net loss of $6.26 million for the nine months ended September 30, 2026, compared to $5.42 million in the prior year period. The company strengthened its cash position to $7.38 million through private placements and warrant exercises, while continuing to invest heavily in research and development for its diagnostic platform.

Key figure
Net loss $2.01M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.